Psychopharmacopeia.com is a progressive web application aimed at providing clinicians with fast access to psychiatric drug information.
Quickly find indications (including off-label), dosing, side effects, clinically useful pharmacokinetic and pharmacodynamic information, drug-drug interactions, and prescribing pearls for special populations i.e. pregnant, lactating, patients with renal or hepatic impairment, elderly, etc. At last, a virtual Rolodex of psychopharm information, accessible anywhere and across devices.
This site is being updated almost daily. Brexanolone is our most recent addition to the rapidly growing drug database.
Check out our new QT reference page with tables summarizing QT prolongation risk factors, including medication tables for both psych and non-psych meds (with comparison of high vs low risk of QT prolongation of various classes of psych meds).
All drugs in the psychopharm database populate our CYP450 table, organized into substrates, inhibitors, and inducers of the major CYP pathways (1A2, 2D6, 2C9/C19, 3A4).
Converting a patient from one benzodiazepine to another? This benzodiazepine conversion tool shows the equipotent dose of the drug you're converting to, while comparing basic pharmacokinetic and prescribing information side-by-side.
The antipsychotic conversion tool allows for quick calculation of equipotent antipsychotic doses for 20 different antipsychotic medications based on published chlorpromazine equivalents and provides suggested cross-taper schedule for making the switch!
The stimulant dose conversion calculator is still in progress, and so far can convert doses to/from among Ritalin, Adderall, Vyvanse, Dexadrine, and Focalin. Look for updates to this conversion tool soon!
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia
Posted on Tuesday January 07, 2020
This randomized clinical trial examines the efficacy and safety of lumateperone for the short-term treatment of adults with schizophrenia.
How to Identify and Fix Sleep Problems
Posted on Tuesday December 31, 2019
This article discusses sleep problems, especially in individuals with psychiatric illnesses.
Association of Intrinsic Brain Architecture With Changes in Attentional and Mood Symptoms During Development
Posted on Wednesday December 25, 2019
This cohort study examines the ability of resting-state networks to predict the developmental trajectory of symptoms associated with attention-deficit/hyperactivity disorder and major depressive disorder in US children.
Association of Antipsychotic Polypharmacy vs Monotherapy With Rehospitalization in Schizophrenia
Posted on Tuesday April 30, 2019
This national cohort study examines the use of polypharmacy vs monotherapy as maintenance treatment among adult patients with schizophrenia who have been rehospitalized for psychiatric treatment in Finland.
Risk of Subjection to and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden
Posted on Tuesday January 14, 2020
This nationwide Swedish cohort study examines the risks of subjection to violence and perpetration of violence among patients with psychiatric disorders compared with siblings and individuals from the general population without psychiatric disorders.
Developed & Designed by Kevin M. Nasky, D.O. • Built with Bootstrap, PHP & MySQL • Hosted by SiteGround
Last updated August 08 2019 14:18:39. Disclaimer: This website does not provide medical advice, nor is it a substitute for clinical judgment.